Hologic (HOLX) Q2 2025 10-Q Quarterly Report
Filed: Jul 31, 2025Period ending Jun 28, 2025
Health Care
X-Ray Apparatus & Tubes & Related Irradiation ApparatusSEC EDGAR Hologic (HOLX) 10-Q quarterly report for Q2 2025, filed with SEC EDGAR on Jul 31, 2025 for the fiscal period ending Jun 28, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
Hologic Q2 2025 10-Q Analysis
Risk Factors
- • No newly added risk factors disclosed this quarter
- • Most materially updated risk: potential material impacts from inaccurate estimates in revenue recognition, asset valuation, and goodwill impairments due to changing assumptions
- • Compliance risk: contingent liabilities and tax reserves subject to changes impacting financial condition materially
- • Operational risk: inventory reserves for excess/obsolete stocks critical due to shifting demand and supply chain uncertainties
- • Financial risk: reliance on estimates affecting valuation of deferred tax assets and related allowance, impacting reported liquidity and financial results
Hologic Q2 2025 Quarterly FinancialsXBRL
Revenue
$1.0B
▲ +1.2% YoY▲ +1.8% QoQ
Net Income
$195M
▲ +0.2% YoY▲ +1220.1% QoQ
Net Margin
19.0%
▼ -19bp YoY▲ +2077bp QoQ
Source: XBRL data from Hologic Q2 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other Hologic Quarterly Reports
Get deeper insights on Hologic
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.